Skip to main content
Home
Conference
Agenda
Faculty
Registration
Abstract Guidelines & FAQs
Venue & Accommodations
Totally RAD Award
Patient-Case Studies
Sponsors
Sponsorship Opportunites
Education & Resources
Articles & Publications
Past Conferences
About
Contact
Home
Conference
Agenda
Faculty
Registration
Abstract Guidelines & FAQs
Venue & Accommodations
Totally RAD Award
Patient-Case Studies
Sponsors
Sponsorship Opportunites
Education & Resources
Articles & Publications
Past Conferences
About
Contact
Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: the Pivotal Phase 3 ADORING Clinical Program